The goal of NORD’s centers of excellence program is to foster collaboration among a network of medical institutions to improve care for the 25 million Americans diagnosed with a rare disease.
“As a NORD-recognized center, Cleveland Clinic will have access to resources and expertise from a large network of institutions working together to innovate around new treatments, therapies and research,” Daniel Sullivan, MD, co-director of the Cleveland Clinic Center for Rare Diseases, said in a May 4 news release.
At Cleveland Clinic, the center will join physicians, medical geneticists, pharmacists and genetic counselors who care for patients with rare conditions. It also includes Cleveland Clinic’s newly unveiled Undiagnosed Disease Clinic, which uses genome sequencing to help find a diagnosis for patients with rare conditions.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
